Correction to: Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling (Journal of Translational Medicine, (2014), 12, 1, (334), 10.1186/s12967-014-0334-7);Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating rankl/rank/opg signaling

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Jiang, Yini ^a   Zhang, Yanqiong ^a   Chen, Weiheng ^b   Liu, Chunfang ^a   Li, Xiaomin ^a   Sun, Danni ^a   Liu, Zhenli ^a   Xu, Ying ^a   Mao, Xia ^a   Guo, Qiuyan ^a   Lin, Na ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b WANGJING HOSPITAL   (China)

Author keywords

Achyranthes bidentata extract; Femoral head; Osteoprotective; RANKL RANK OPG signaling pathway; Steroid induced osteonecrosis

Indexed keywords

ACHYRANTHES BIDENTATA EXTRACT; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STEROID; TRIACYLGLYCEROL; PLANT EXTRACT; PREDNISOLONE; PRIMER DNA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTI OSTEOCLASTOGENIC EFFECT; ARTICLE; BONE DENSITY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MASS; BONE MICROARCHITECTURE; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; EMPTY LACUNA; FEMUR HEAD NECROSIS; IN VITRO STUDY; IN VIVO STUDY; JOINT CAVITY; MALE; MICROFOCAL COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRABECULAR BONE; UPREGULATION; ACHYRANTHES; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMUR HEAD; METABOLISM; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEONECROSIS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ACHYRANTHES; ANIMALS; BASE SEQUENCE; BONE DENSITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; DNA PRIMERS; FEMUR HEAD; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEONECROSIS; OSTEOPROTEGERIN; PLANT EXTRACTS; PREDNISOLONE; RANK LIGAND; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84964314325     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-021-02867-6     Document Type: Erratum

References (34)

1. Wang XS, Zhuang QY, Weng XS, Lin J, Jin J, Qian WW: Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients. Chin Med J (Engl) 2013, 126:290-295.
2. Moriya M, Uchiyama K, Takahira N, Fukushima K, Yamamoto T, Hoshi K, Itoman M, Takaso M: Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head. Int Orthop 2012, 36:2041-2047.
3. Aimaiti A, Wufuer M, Wang YH, Saiyiti M, Cui L, Yusufu A: Can bisphenol A diglycidyl ether (BADGE) administration prevent steroid-induced femoral head osteonecrosis in the early stage? Med Hypotheses 2011, 77:282-285.
4. Mikami T, Ichiseki T, Kaneuji A, Ueda Y, Sugimori T, Fukui K, Matsumoto T: Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. J Orthop Sci 2010, 15:674-677.
5. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME: Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 2010, 9:721-743.
6. Li J, Qi H, Qi LW, Yi L, Li P: Simultaneous determination of main phytoecdysones and triterpenoids in radix achyranthis bidentatae by highperformanceliquid chromatography with diode array-evaporative light scattering detectors and mass spectrometry. Anal Chim Acta 2007, 596:264-272.
7. Committee of National Pharmacopoeia: Pharmacopoeia of the People's Republic of China. Beijing: Chemical Industry Press; 2005:49.
8. Chen Q, Liu Z, He JH: Achyranthes bidentat polysaccharide enhances immune response in weaned piglets. Immunopharmacol Immunotoxicol 2009, 31:253-260.
9. Han SB, Lee CW, Yoon YD, Lee JH, Kang JS, Lee KH, Yoon WK, Lee K, Park SK, Kim HM: Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from achyranthes bidentat and atractylodes japonic. Arch Pharm Res 2005, 28:902-908.
10. Cheng J, Di LQ, Shan JJ, Zhao XL, Kang A, Bi XL, Li JS: Studies on effects of Achyranthes bidentata on tongsaimai pellets main active ingredients chlorogenic acid, isoliquiritin, harpagoside and glycyrrhizin in vivo pharmacokinetics. Zhongguo Zhong Yao Za Zhi 2014, 39:1502-1508.
11. Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S: Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med 2005, 71:673-679.
12. Gao XY, Wang DW, Li FM: Determination of ecdysterone in Achyranthes bidentata BL. and its activity promoting proliferation of osteoblast-like cells. Yao Xue Xue Bao 2000, 35:868-870.
13. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M: Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 2004, 15:285-295.
14. Bitto A, Polito F, Burnett B, Levy R, Di Stefano V, Armbruster MA, Marini H, Minutoli L, Altavilla D, Squadrito F: Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats. J Endocrinol 2009, 201:321-328.
15. Han N, Yan Z, Guo CA, Shen F, Liu J, Shi Y, Zhang Z: Effects ofp-glycoprotein on steroid-induced osteonecrosis of the femoral head. Calcif Tissue Int 2010, 87:246-253.
16. Yamamoto T, Irisa T, Sugioka Y, Sueishi K: Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997, 40:2055-2064.
17. Sun Y, Feng Y, Zhang C, Cheng X, Chen S, Ai Z, Zeng B: Beneficial effect of autologous transplantation of endothelial progenitor cells on steroid-induced femoral head osteonecrosis in rabbits. Cell Transplant 2011, 20:233-243.
18. Sun Y, Feng Y, Zhang C: The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 2009, 76:685-690.
19. Lin N, Liu C, Xiao C, Jia H, Imada K, Wu H, Ito A: Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol 2007, 73:136-146.
20. Kerachian MA, Seguin C, Harvey EJ: Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 2009, 114:121-128.
21. Zhang R, Hu S, Li C, Zhang F, Gan H, Mei Q: Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. J Ethnopharmacol 2012, 139:12-18.
22. Hu J, Qi YX, Li QX, Shan BE: The research of extract of achyranthes bidentata blume anti-tumor activity. Chin J Microbiol Immunol 2005, 25:415-418.
23. He C, Hui R, Tezuka Y, Kadota S, Li J: Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats. J Ethnopharmacol 2010, 127:229-234.
24. Teitelbaum SL: Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
25. Eriksen EF, Mosekilde L, Melsen F: Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 1985, 6:421-428.
26. Oursler MJ, Landers JP, Riggs BL, Spelsberg TC: Oestrogen effects on osteoblasts and osteoclasts. J Ann Med 1993, 25:361-371.
27. Bai YD, Yang FS, Xuan K, Bai YX, Wu BL: Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med Hypotheses 2008, 71:256-258.
28. Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM: RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 2005, 38:161-170.
29. Geusens P: The role of RANK ligand/osteoprotegerin in rheumatoid arthritis. Ther Adv Musculoskelet Dis 2012, 4:225-233.
30. Ho TY, Santora K, Chen JC, Frankshun AL, Bagnell CA: Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Bone 2011, 48:1346-1353.
31. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
32. Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH: Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. J Bone Miner Res 2000, 15:2178-2186.
33. Shao B, Yu Y, Fu X, Xue H, Qi M, Shuai Y, Zhou Z, Jin Y, Yang D: RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2013, 29:1262-1266.
34. Mbalaviele G, Jaiswal N, Meng A, Cheng L, Van Den Bos C, Thiede M: Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 1999, 140:3736-3743.